Teligent EBITDA Margin 2012-2021 | TLGT
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Teligent (TLGT) over the last 10 years. The current EBITDA margin for Teligent as of June 30, 2021 is .
| Teligent EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2021-06-30 | $0.05B | $-0.13B | -280.43% |
| 2021-03-31 | $0.05B | $-0.12B | -240.00% |
| 2020-12-31 | $0.05B | $-0.13B | -282.22% |
| 2020-09-30 | $0.05B | $-0.02B | -47.06% |
| 2020-06-30 | $0.06B | $-0.02B | -29.09% |
| 2020-03-31 | $0.06B | $-0.01B | -18.64% |
| 2019-12-31 | $0.07B | $0.00B | 6.15% |
| 2019-09-30 | $0.07B | $0.01B | 7.58% |
| 2019-06-30 | $0.07B | $0.00B | 6.06% |
| 2019-03-31 | $0.06B | $0.00B | -1.56% |
| 2018-12-31 | $0.07B | $0.00B | -1.52% |
| 2018-09-30 | $0.06B | $0.00B | -3.33% |
| 2018-06-30 | $0.05B | $-0.01B | -15.09% |
| 2018-03-31 | $0.06B | $0.00B | -5.45% |
| 2017-12-31 | $0.06B | $0.00B | 5.00% |
| 2017-09-30 | $0.06B | $0.01B | 14.29% |
| 2017-06-30 | $0.07B | $0.02B | 23.53% |
| 2017-03-31 | $0.07B | $0.02B | 23.88% |
| 2016-12-31 | $0.06B | $0.01B | 22.22% |
| 2016-09-30 | $0.06B | $0.01B | 17.74% |
| 2016-06-30 | $0.06B | $0.01B | 17.24% |
| 2016-03-31 | $0.05B | $0.01B | 12.00% |
| 2015-12-31 | $0.05B | $0.01B | 11.11% |
| 2015-09-30 | $0.05B | $0.01B | 21.74% |
| 2015-06-30 | $0.04B | $0.01B | 19.51% |
| 2015-03-31 | $0.04B | $0.01B | 21.05% |
| 2014-12-31 | $0.03B | $0.01B | 14.71% |
| 2014-09-30 | $0.03B | $0.00B | 3.70% |
| 2014-06-30 | $0.02B | $0.00B | 4.17% |
| 2014-03-31 | $0.02B | $0.00B | 4.55% |
| 2013-12-31 | $0.02B | $0.00B | 5.26% |
| 2013-09-30 | $0.01B | $0.00B | -7.14% |
| 2013-06-30 | $0.01B | $0.00B | -8.33% |
| 2013-03-31 | $0.01B | $0.00B | -10.00% |
| 2012-12-31 | $0.01B | $0.00B | -25.00% |
| 2012-09-30 | $0.01B | $0.00B | -25.00% |
| 2012-06-30 | $0.01B | $0.00B | -25.00% |
| 2012-03-31 | $0.01B | $0.00B | -37.50% |
| 2011-12-31 | $0.01B | $0.00B | -37.50% |
| 2011-09-30 | $0.01B | $0.00B | -37.50% |
| 2011-06-30 | $0.01B | $0.00B | -50.00% |
| 2011-03-31 | $0.01B | $0.00B | -50.00% |
| 2010-12-31 | $0.01B | $0.00B | -57.14% |
| 2010-09-30 | $0.01B | $0.00B | -66.67% |
| 2010-06-30 | $0.01B | $0.00B | -80.00% |
| 2010-03-31 | $0.00B | $0.00B | -75.00% |
| 2009-12-31 | $0.00B | $0.00B | -75.00% |
| 2009-09-30 | $0.00B | $0.00B | -75.00% |
| 2009-06-30 | $0.00B | $0.00B | -50.00% |
| 2009-03-31 | $0.00B | $0.00B | -75.00% |
| 2008-12-31 | $0.01B | $0.00B | -40.00% |
| 2008-09-30 | $0.01B | $0.00B | -16.67% |
| 2008-06-30 | $0.01B | $0.00B | -16.67% |
| 2008-03-31 | $0.01B | 0 | 0.00% |
| 2007-12-31 | $0.01B | 0 | 0.00% |
| 2007-09-30 | $0.00B | $0.00B | -25.00% |
| 2007-06-30 | $0.00B | $0.00B | -25.00% |
| 2007-03-31 | $0.00B | $0.00B | -25.00% |
| 2006-12-31 | $0.00B | $0.00B | -25.00% |
| 2006-09-30 | $0.00B | 0 | 0.00% |
| 2006-06-30 | $0.00B | 0 | 0.00% |
| 2006-03-31 | $0.00B | 0 | 0.00% |
| 2005-12-31 | $0.00B | 0 | 0.00% |
| 2005-09-30 | $0.00B | 0 | 0.00% |
| 2005-06-30 | $0.00B | 0 | 0.00% |
| 2005-03-31 | $0.00B | $0.00B | -25.00% |
| 2004-12-31 | $0.00B | $0.00B | -25.00% |
| 2004-09-30 | $0.00B | $0.00B | -25.00% |
| 2004-06-30 | $0.00B | $0.00B | -25.00% |
| 2004-03-31 | $0.00B | 0 | 0.00% |
| 2003-12-31 | $0.00B | 0 | 0.00% |
| 2003-09-30 | $0.00B | 0 | 0.00% |
| 2003-06-30 | $0.00B | 0 | 0.00% |
| 2003-03-31 | $0.00B | 0 | 0.00% |
| 2002-12-31 | $0.00B | $0.00B | 25.00% |
| 2002-09-30 | $0.01B | $0.00B | 10.00% |
| 2002-06-30 | $0.01B | $0.00B | 15.38% |
| 2002-03-31 | $0.02B | $0.00B | 18.75% |
| 2001-12-31 | $0.02B | $0.00B | 18.75% |
| 2001-09-30 | $0.02B | $0.01B | 68.75% |
| 2001-06-30 | $0.02B | $0.01B | 56.25% |
| 2001-03-31 | $0.02B | $0.01B | 29.41% |
| 2000-12-31 | $0.02B | $0.00B | 11.11% |
| 2000-09-30 | $0.02B | $-0.01B | -47.37% |
| 2000-06-30 | $0.02B | $-0.01B | -55.00% |
| 2000-03-31 | $0.02B | $-0.01B | -47.62% |
| 1999-12-31 | $0.02B | $-0.01B | -52.38% |
| 1999-09-30 | $0.03B | $-0.01B | -32.00% |
| 1999-06-30 | $0.03B | $-0.01B | -17.86% |
| 1999-03-31 | $0.03B | $0.00B | -13.33% |
| 1998-12-31 | $0.03B | 0 | 0.00% |
| 1998-09-30 | $0.03B | $0.00B | -6.25% |
| 1998-06-30 | $0.03B | $0.00B | -3.03% |
| 1998-03-31 | $0.03B | $0.00B | 2.94% |
| 1997-12-31 | $0.04B | $0.00B | 2.86% |
| 1997-09-30 | $0.04B | $0.00B | 8.33% |
| 1997-06-30 | $0.04B | $0.00B | 8.57% |
| 1997-03-31 | $0.04B | $0.00B | 8.57% |
| 1996-12-31 | $0.04B | $0.00B | 8.57% |
| 1996-09-30 | $0.03B | $0.00B | 8.82% |
| 1996-06-30 | $0.03B | $0.00B | 8.82% |
| 1996-03-31 | $0.03B | $0.00B | 9.09% |
| 1995-12-31 | $0.03B | $0.00B | 9.68% |
| 1995-09-30 | $0.03B | $0.00B | 9.68% |
| 1995-06-30 | $0.03B | $0.00B | 10.00% |
| 1995-03-31 | $0.03B | $0.00B | 10.34% |
| 1994-12-31 | $0.03B | $0.00B | 10.34% |
| 1994-09-30 | $0.03B | $0.01B | 21.43% |
| 1994-06-30 | $0.03B | $0.01B | 17.86% |
| 1994-03-31 | $0.03B | $0.00B | 14.29% |
| 1993-12-31 | $0.03B | $0.00B | 10.71% |
| 1993-09-30 | $0.03B | 0 | 0.00% |
| 1993-06-30 | $0.03B | 0 | 0.00% |
| 1993-03-31 | $0.03B | 0 | 0.00% |
| 1992-12-31 | $0.02B | 0 | 0.00% |
| 1992-09-30 | $0.02B | 0 | 0.00% |
| 1992-06-30 | $0.02B | 0 | 0.00% |
| 1992-03-31 | $0.02B | 0 | 0.00% |
| 1991-12-31 | $0.02B | 0 | 0.00% |
| 1991-09-30 | $0.02B | 0 | 0.00% |
| 1991-06-30 | $0.02B | 0 | 0.00% |
| 1991-03-31 | $0.02B | 0 | 0.00% |
| 1990-12-31 | $0.02B | 0 | 0.00% |
| 1990-09-30 | $0.02B | 0 | 0.00% |
| 1990-06-30 | $0.02B | 0 | 0.00% |
| 1990-03-31 | $0.02B | 0 | 0.00% |
| 1989-12-31 | $0.02B | 0 | 0.00% |
| 1989-09-30 | $0.02B | 0 | 0.00% |
| 1989-06-30 | $0.02B | 0 | 0.00% |
| 1989-03-31 | $0.02B | 0 | 0.00% |
| 1988-12-31 | $0.02B | 0 | 0.00% |
| 1988-09-30 | $0.02B | 0 | 0.00% |
| 1988-06-30 | $0.02B | 0 | 0.00% |
| 1988-03-31 | $0.02B | $0.00B | 6.25% |
| 1987-12-31 | $0.02B | $0.00B | 6.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.000B | $0.000B |
| Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $44.899B | 17.67 |
| BridgeBio Pharma (BBIO) | United States | $13.352B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $9.749B | 24.85 |
| Aspen Pharmacare (APNHY) | South Africa | $4.248B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.409B | 20.18 |
| Bausch Health Cos (BHC) | Canada | $2.129B | 1.33 |
| Personalis (PSNL) | United States | $1.687B | 0.00 |
| Taysha Gene Therapies (TSHA) | United States | $1.652B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $1.019B | 9.58 |
| Assembly Biosciences (ASMB) | United States | $0.519B | 24.98 |
| Sol-Gel Technologies (SLGL) | Israel | $0.178B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.043B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |